Sprucegrove Investment Management LTD Maintains Position in Intel (INTC); As Novo (NVO) Share Price Rose, Holder Lagoda Investment Management LP Has Decreased Stake by $845,712

January 22, 2018 - By Nellie Frank

Lagoda Investment Management Lp decreased its stake in Novo (NVO) by 4.03% based on its latest 2017Q3 regulatory filing with the SEC. Lagoda Investment Management Lp sold 17,619 shares as the company’s stock rose 15.20% with the market. The institutional investor held 419,324 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $20.19M, down from 436,943 at the end of the previous reported quarter. Lagoda Investment Management Lp who had been investing in Novo for a number of months, seems to be less bullish one the $139.43 billion market cap company. The stock increased 0.22% or $0.13 during the last trading session, reaching $57.92. About 852,852 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since January 22, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Sprucegrove Investment Management Ltd increased its stake in Intel Corp (INTC) by 37.83% based on its latest 2017Q3 regulatory filing with the SEC. Sprucegrove Investment Management Ltd bought 131,400 shares as the company’s stock declined 2.96% while stock markets rallied. The institutional investor held 478,740 shares of the semiconductors company at the end of 2017Q3, valued at $18.23 million, up from 347,340 at the end of the previous reported quarter. Sprucegrove Investment Management Ltd who had been investing in Intel Corp for a number of months, seems to be bullish on the $213.81B market cap company. The stock increased 1.93% or $0.87 during the last trading session, reaching $45.69. About 16.54 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since January 22, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. Piper Jaffray initiated Novo Nordisk A/S (NYSE:NVO) on Friday, September 23 with “Neutral” rating. Goldman Sachs maintained Novo Nordisk A/S (NYSE:NVO) on Friday, January 19 with “Buy” rating. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Underperform” rating by Bank of America on Friday, October 28. The stock of Novo Nordisk A/S (NYSE:NVO) has “Hold” rating given on Friday, December 29 by J.P. Morgan. The company was downgraded on Friday, September 9 by JP Morgan. JP Morgan upgraded the stock to “Neutral” rating in Friday, December 29 report. Zacks upgraded it to “Hold” rating and $63 target in Friday, August 28 report. The stock of Novo Nordisk A/S (NYSE:NVO) has “Neutral” rating given on Wednesday, September 6 by Bank of America. DNB Markets downgraded the shares of NVO in report on Monday, October 31 to “Hold” rating. Morgan Stanley downgraded the shares of NVO in report on Thursday, September 1 to “Equal-Weight” rating.

Lagoda Investment Management Lp, which manages about $725.00 million and $276.68M US Long portfolio, upped its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 1,285 shares to 55,717 shares, valued at $24.91M in 2017Q3, according to the filing. It also increased its holding in Digimarc Corp New (NASDAQ:DMRC) by 20,750 shares in the quarter, for a total of 687,296 shares, and has risen its stake in Cimarex Energy Co (NYSE:XEC).

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on February, 1. They expect $0.56 earnings per share, up 12.00% or $0.06 from last year’s $0.5 per share. NVO’s profit will be $1.35B for 25.86 P/E if the $0.56 EPS becomes a reality. After $0.62 actual earnings per share reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Sprucegrove Investment Management Ltd, which manages about $24.66B and $1.78B US Long portfolio, decreased its stake in Mdu Res Group Inc (NYSE:MDU) by 15,200 shares to 636,000 shares, valued at $16.50 million in 2017Q3, according to the filing. It also reduced its holding in Procter & Gamble Co (NYSE:PG) by 5,600 shares in the quarter, leaving it with 238,200 shares, and cut its stake in Cullen Frost Bankers (NYSE:CFR).

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 34 have Buy rating, 5 Sell and 15 Hold. Therefore 63% are positive. Intel Corporation had 207 analyst reports since August 7, 2015 according to SRatingsIntel. Needham maintained Intel Corporation (NASDAQ:INTC) on Saturday, August 29 with “Buy” rating. On Wednesday, September 23 the stock rating was upgraded by Bernstein to “Mkt Perform”. The stock of Intel Corporation (NASDAQ:INTC) earned “Buy” rating by Brean Capital on Wednesday, October 19. Canaccord Genuity maintained it with “Buy” rating and $44 target in Tuesday, September 20 report. The stock of Intel Corporation (NASDAQ:INTC) earned “Buy” rating by KeyBanc Capital Markets on Monday, September 11. As per Thursday, January 14, the company rating was initiated by SunTrust. On Monday, August 24 the stock rating was maintained by Citigroup with “Neutral”. Deutsche Bank maintained it with “Buy” rating and $40 target in Thursday, July 21 report. The stock of Intel Corporation (NASDAQ:INTC) earned “Neutral” rating by Goldman Sachs on Wednesday, April 20. The stock has “Hold” rating by RBC Capital Markets on Monday, June 5.

Since July 31, 2017, it had 0 insider purchases, and 10 selling transactions for $31.43 million activity. 30,000 shares were sold by YOFFIE DAVID B, worth $1.35 million. Another trade for 61,860 shares valued at $2.40M was made by Krzanich Brian M on Monday, October 2. Smith Stacy J also sold $20.89 million worth of Intel Corporation (NASDAQ:INTC) shares. RENDUCHINTALA VENKATA S M sold $51,834 worth of stock. 89,087 shares were sold by BRYANT ANDY D, worth $3.99 million.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>